Article
Membrane-anchored and tumor-targeted Il-12(attIL12) PBMC therapy for osteosarcoma
2022-03-02
Abstract excerpt
<h4>Background: </h4> Chimeric antigen receptor (CAR) T cell therapy has shown great promise for hematologic malignancies but requires a long duration of T-cell expansion, is associated with severe toxicity, and has limited efficacy for treating solid tumor. Methods To address these challenges, we generated a cell membrane-anchored and tumor-targeted interleukin-12 (attIL12) to arm peripheral blood mononuclear ce...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 646f4a91-cb6c-51d7-a13e-eb74b9925cce
- DOI
- 10.21203/rs.3.rs-1392663/v1
